Cryptococcal peritonitis in a CAPD patient

REFERENCES

• Amair P., Khanna R., Leibel B., Pierratos A., Vas S., Meema E., Blair G., Chisolm L., Vas M., Zingg W., Digenis G., Oreopoulos D. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. New England Journal of Medicine 1982; 306: 625–630
   PubMed Web of Science ®Google Scholar
• Ampel N.M., White J.D., Varanasi U.R., Larwood T.R., Van Wyck D.B., Galgani J.N. Coccidioidal peritonitis associated with continuous ambulatory peritoneal dialysis. American Journal of Kidney Disease 1988; 11: 512–514
   PubMed Web of Science ®Google Scholar
• Benevent D., Reyronnet P., Lagarde C., Leroux-Robert C. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Three recoveries in 5 cases without catheter removal. Nephron 1985; 41: 203–206
   PubMed Web of Science ®Google Scholar
• Chapman J.R., Warnock D.W. Ketoconazole and fungal CAPD peritonitis (Correspondence). Lancet 1983; ii: 510–511
   Google Scholar
• Cheng I.K.P., Fang G-X., Chan T-M., Chan P.C.K., Chan M-K. Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment. Quarterly Journal of Medicine (Oxford) 1989; 71: 407–416
   Google Scholar
• Eisenberg E.S., Leviton I., Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Reviews of Infectious Diseases 1986; 8: 309–321
   PubMedGoogle Scholar
• Ellis D.H., Pfeiffer T.J. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990; ii: 923–925
   Google Scholar
• Gokal R., Ramos J.M., Francis D.M.A., Ferner R.E., Goodship T.H.J., Proud G., Bint A.J., Ward M.K., Kerr M.K. Peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1982; ii: 1388–1391
   Google Scholar
• Hay R.J. Antifungal therapy and the new azole compounds. Journal of Antimicrobial Chemotherapy 1991; 28(Supplement A)35–46
   PubMedGoogle Scholar
• Kaczmarski E.B., Tooth J.A., Anastassiades E., Manos J., Gokal R. Cryptococcosis complicating continuous ambulatory peritoneal dialysis. Journal of Infection 1989; 18: 289–292
   PubMed Web of Science ®Google Scholar
• Keogh J.A.B., Carr M.E., Murray F., McEvoy M., Grant G., Keane C.T. Treatment of fungal peritonitis in CAPD patients using peritoneal lavage. Peritoneal Dialysis Bulletin 1985; 5: 67–69
   Google Scholar
• Kerr C.M., Perfect J.R., Craven P.C., Jorgensen J.H., Drutz D.J., Shelburne J.D., Gallis H.A., Gutman R.A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Annals of Internal Medicine 1983; 99: 334–337
   PubMed Web of Science ®Google Scholar
• Kraus E.S., Spector D.A. Characteristics and sequelae of peritonitis in diabetics and non-diabetics receiving chronic intermittent peritoneal dialysis. Medicine 1983; 62: 52–57
   PubMed Web of Science ®Google Scholar
• Kwon-chung K.J., Polacheck I., Bennett J.E. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). Journal of Clinical Microbiology 1982; 15: 535–537
   PubMed Web of Science ®Google Scholar
• Lempert K.D., Jones J.M. Flucytosine-miconazole treatment of Candida peritonitis. Archives of Internal Medicine 1982; 142: 577–578
   PubMedGoogle Scholar
• Levine J., Bernard D.B., Idelson B.A., Farnham H., Saunders C., Sugar A.M. Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. American Journal of Medicine 1989; 86: 825–827
   PubMed Web of Science ®Google Scholar
• McGuire N.M., Port F.K., Kauffman C.A. Ketoconazole pharmacokinetics in continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Bulletin 1984; 4: 199–201
   Google Scholar
• Morford D.W., Sandroni S.E. Cryptococcal peritonitis review. Advances in CAPD, Proceedings of the 6th Annual CAPD Conference, R. Khanna, K. Nolph, B. Prowant, Z. Twardowski, D. Oreopoulous. University of Toronto Press, Toronto 1986; 141–142, Kansas, Missouri
   Google Scholar
• Parsons F.M., Ahmed-Jushuf I.H., Brownjohn A.M., Coltman S.J., Gibson J., Young G.A., Young J.B. CAPD peritonitis. Lancet 1983; i: 348–349
   Google Scholar
• Poblete R.B., Kirby B.D. Cryptococcal peritonitis — report of a case and review of the literature. American Journal of Medicine 1987; 82: 665–667
   PubMed Web of Science ®Google Scholar
• Polo J.R., Luno J., Menarguez C., Gallego E., Robles R., Hernandez P. Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. American Journal of Kidney Disease 1989; 13: 237–239
   PubMed Web of Science ®Google Scholar
• Report of a working party of the British Society for Antimicrobial Chemotherapy. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1987; i: 845–849
   Google Scholar
• Rubin J., Rogers W.A., Taylor H.M., Everett D., Prowant B.F., Fruto L.V., Nolph K.D. Peritonitis during continuous ambulatory peritoneal dialysis. Annals of Internal Medicine 1980; 92: 7–13
   PubMed Web of Science ®Google Scholar
• Smith J.M.B. Opportunistic Mycoses of Man and Other Animals. C.A.B. International Mycological Institute, London 1989; 53–80
   Google Scholar
• Sugar A.M., Stern J.J., Dupont B. Overview: treatment of cryptococcal meningitis. Reviews of Infectious Diseases 1990; 12(Supplement 3)S338–S348
   PubMedGoogle Scholar
• Valainis G.T., Morford D.W. Ketoconazole levels in peritoneal fluid (Correspondence). Peritoneal Dialysis Bulletin, 5: 136–136
   Google Scholar
• Vas S.I. Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney International 1983; 23: 83–91
   PubMed Web of Science ®Google Scholar
• Wang F. Cryptococcus peritonitis (Correspondence). Peritoneal Dialysis Bulletin 1985; 5: 78–78
   Google Scholar
• Wang F. Cryptococcus peritonitis. Singapore Medical Journal 1988; 29: 88–89
   PubMedGoogle Scholar